Regina K Rowe1, Michelle A Gill2,3,4. 1. Department of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9063, USA. 2. Department of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9063, USA. Michelle.Gill@UTSouthwestern.edu. 3. Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Michelle.Gill@UTSouthwestern.edu. 4. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. Michelle.Gill@UTSouthwestern.edu.
Abstract
PURPOSE OF REVIEW: Multiple clinical and epidemiological studies demonstrate links between allergic sensitization and virus-induced atopic disease exacerbations. This review summarizes the recent findings regarding allergen, viral, and host cellular mechanisms relevant to these observations. RECENT FINDINGS: Recent studies have focused on the molecular pathways and genetic influences involved in allergen-mediated inhibition of innate antiviral immune responses. Multiple tissue and cell types from atopic individuals across the atopy spectrum exhibit deficient interferon responses to a variety of virus infections. Impairment in barrier function, viral RNA and DNA recognition by intracellular sensing molecules, and dysregulation of signaling components are broadly affected by allergic sensitization. Finally, genetic predisposition by numerous nucleotide polymorphisms also impacts immune pathways and potentially contributes to virus-associated atopic disease pathogenesis. Allergen-virus interactions in the setting of atopy involve complex tissue and cellular mechanisms. Future studies defining the pathways underlying these interactions could uncover potential therapeutic targets. Available data suggest that therapies tailored to restore specific components of antiviral responses will likely lead to improved clinical outcomes in allergic disease.
PURPOSE OF REVIEW: Multiple clinical and epidemiological studies demonstrate links between allergic sensitization and virus-induced atopic disease exacerbations. This review summarizes the recent findings regarding allergen, viral, and host cellular mechanisms relevant to these observations. RECENT FINDINGS: Recent studies have focused on the molecular pathways and genetic influences involved in allergen-mediated inhibition of innate antiviral immune responses. Multiple tissue and cell types from atopic individuals across the atopy spectrum exhibit deficient interferon responses to a variety of virus infections. Impairment in barrier function, viral RNA and DNA recognition by intracellular sensing molecules, and dysregulation of signaling components are broadly affected by allergic sensitization. Finally, genetic predisposition by numerous nucleotide polymorphisms also impacts immune pathways and potentially contributes to virus-associated atopic disease pathogenesis. Allergen-virus interactions in the setting of atopy involve complex tissue and cellular mechanisms. Future studies defining the pathways underlying these interactions could uncover potential therapeutic targets. Available data suggest that therapies tailored to restore specific components of antiviral responses will likely lead to improved clinical outcomes in allergic disease.
Authors: Tess M Becker; Sandy R Durrani; Yury A Bochkov; Mark K Devries; Victoria Rajamanickam; Daniel J Jackson Journal: Ann Allergy Asthma Immunol Date: 2013-08-28 Impact factor: 6.347
Authors: Daniel J Jackson; Ronald E Gangnon; Michael D Evans; Kathy A Roberg; Elizabeth L Anderson; Tressa E Pappas; Magnolia C Printz; Wai-Ming Lee; Peter A Shult; Erik Reisdorf; Kirsten T Carlson-Dakes; Lisa P Salazar; Douglas F DaSilva; Christopher J Tisler; James E Gern; Robert F Lemanske Journal: Am J Respir Crit Care Med Date: 2008-06-19 Impact factor: 21.405
Authors: Simon D Message; Vasile Laza-Stanca; Patrick Mallia; Hayley L Parker; Jie Zhu; Tatiana Kebadze; Marco Contoli; Gwen Sanderson; Onn M Kon; Alberto Papi; Peter K Jeffery; Luminita A Stanciu; Sebastian L Johnston Journal: Proc Natl Acad Sci U S A Date: 2008-09-03 Impact factor: 11.205
Authors: Pei-Song Gao; Nicholas M Rafaels; Tracey Hand; Tanda Murray; Mark Boguniewicz; Tissa Hata; Lynda Schneider; Jon M Hanifin; Richard L Gallo; Li Gao; Terri H Beaty; Lisa A Beck; Kathleen C Barnes; Donald Y M Leung Journal: J Allergy Clin Immunol Date: 2009-09 Impact factor: 10.793
Authors: Luke Hatchwell; Adam Collison; Jason Girkin; Kristy Parsons; Junyao Li; Jie Zhang; Simon Phipps; Darryl Knight; Nathan W Bartlett; Sebastian L Johnston; Paul S Foster; Peter A B Wark; Joerg Mattes Journal: Thorax Date: 2015-06-24 Impact factor: 9.139
Authors: Antony Hardjojo; Anne Goh; Lynette P C Shek; Hugo P S Van Bever; Oon Hoe Teoh; Jian Yi Soh; Biju Thomas; Boon Huan Tan; Yiong Huak Chan; Mahesh Babu Ramamurthy; Daniel Y T Goh; Shu-E Soh; Seang-Mei Saw; Kenneth Kwek; Yap-Seng Chong; Keith M Godfrey; Peter D Gluckman; Bee Wah Lee Journal: Pediatr Allergy Immunol Date: 2015-02 Impact factor: 6.377
Authors: Charu Rajput; Mingyuan Han; J Kelley Bentley; Jing Lei; Tomoko Ishikawa; Qian Wu; Joanna L Hinde; Amy P Callear; Terri L Stillwell; William T Jackson; Emily T Martin; Marc B Hershenson Journal: JCI Insight Date: 2018-08-23
Authors: Adnan Custovic; Danielle Belgrave; Lijing Lin; Eteri Bakhsoliani; Aurica G Telcian; Roberto Solari; Clare S Murray; Ross P Walton; John Curtin; Michael R Edwards; Angela Simpson; Magnus Rattray; Sebastian L Johnston Journal: Am J Respir Crit Care Med Date: 2018-05-15 Impact factor: 21.405